© New York Post/Creative Commons
The human papillomavirus (HPV) vaccine is given to prevent the risk of cancer associated with HPV and is typically administered between the ages of eight and 26. Opponents argue that not only is the vaccine risky, but it is of no value.
The
HPV vaccine effects are said to last for only about five years.
In a
Health Impact News Daily Post dated today, Dr. Mark Flannery states that, "The problem with this
vaccine is this: Even though it's estimated 60 percent of women have the
HPV virus, only 1-2 percent of the total population gets cervical cancer, and most of those women get the cancer in their 50s. If the vaccine only works for five years, is administered up to age 26, and yet most cases of cervical cancer happen to women in their 50s, the benefits of the Gardasil vaccine are questionable given the severe consequences it can cause."
In Dr. Flannery's practice, he has worked with a number of people
injured by the Gardasil vaccine for HPV and, according to
SaneVax, Inc., as of 2013
more than 32,000 people have reported adverse affects to the Gardasil vaccine, more than 145 have died, over 1,000 are permanently disabled, and more than 6,400 have yet to recover. Dr. Flannery writes, "The evidence shows HPV rarely proceeds to cancer and that very few women with HPV develop cervical cancer, as other risk factors are involved."
Comment: The pharmaceutical industry seems to be doing well...